CLS - CLI Share Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CLS in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CLI shares.
View CLI analyst ratings or view top-rated stocks.

4 analysts have issued 1 year price targets for CLS's shares. Their CLI share price forecasts range from GBX 255 to GBX 290. On average, they predict the company's share price to reach GBX 273.75 in the next twelve months. This suggests a possible upside of 92.5% from the stock's current price.
View analysts price targets for CLI or view top-rated stocks among Wall Street analysts.

CLS's stock was trading at GBX 218.50 at the beginning of the year. Since then, CLI stock has decreased by 34.9% and is now trading at GBX 142.22.
View the best growth stocks for 2022 here.

CLS Holdings plc (LON:CLI) released its quarterly earnings results on Wednesday, August, 12th. The company reported $5.30 earnings per share (EPS) for the quarter.

CLS declared a dividend on Wednesday, August 10th. Investors of record on Thursday, September 8th will be given a dividend of GBX 2.60 per share on Monday, October 3rd. This represents a yield of 1.25%. The ex-dividend date is Thursday, September 8th. The official announcement can be seen at this link.
Read our dividend analysis for CLI.

CLS (LON:CLI) pays an annual dividend of GBX 0.08 per share and currently has a dividend yield of 5.31%. CLI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 24.84%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CLI.

Based on aggregate information from My MarketBeat watchlists, some companies that other CLS investors own include Bank of Hawaii (BOH), InterDigital (IDCC), Derwent London (DLN), Oracle (ORCL), Petrofac (PFC), STAG Industrial (STAG), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE) and Agios Pharmaceuticals (AGIO).

CLS trades on the London Stock Exchange (LON) under the ticker symbol "CLI."

Shares of CLI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of CLI stock can currently be purchased for approximately GBX 142.22.

CLS (LON:CLI) has a market capitalization of £579.41 million and generates £140.40 million in revenue each year.

The company employs 112 workers across the globe.

CLS's mailing address is 86 Bondway, LONDON, SW8 1SF, United Kingdom. The official website for the company is www.clsholdings.com. The company can be reached via phone at +44-20-75827766.